Literature DB >> 17098369

Examination of contingency payments to dually-diagnosed patients in a multi-faceted behavioral treatment.

Joanna E Strong Kinnaman1, Eric Slade, Melanie E Bennett, Alan S Bellack.   

Abstract

Contingency management (CM) may be a promising component of treatment to help dually-diagnosed patients reduce their substance use. However, most prior studies examining CM with these patients have not examined the relationships among patient variables and contingency rewards received. This study examined whether characteristics of dually-diagnosed patients were related to CM payments received in a multi-faceted program. Fifty-nine dually-diagnosed patients participated in a multimodal behavioral therapy for illicit substance use involving CM. Baseline demographic and clinical characteristics were examined as they related to receipt of payments. Demographic characteristics generally were not related to receipt of payments. Several clinical variables, including diagnosis of schizophrenia, current substance dependence, and co-morbid alcohol dependence were related to payment receipt. These results provide an important step toward understanding the characteristics of dually-diagnosed patients that predict their response to CM.

Entities:  

Mesh:

Year:  2006        PMID: 17098369      PMCID: PMC1978222          DOI: 10.1016/j.addbeh.2006.10.003

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  11 in total

Review 1.  Clinical implications of reinforcement as a determinant of substance use disorders.

Authors:  Stephen T Higgins; Sarah H Heil; Jennifer Plebani Lussier
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

2.  Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.

Authors:  Jennifer W Tidey; Suzanne C O'Neill; Stephen T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2002-08       Impact factor: 3.157

3.  Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study.

Authors:  John M Roll; Stephen T Chermack; Joy E Chudzynski
Journal:  Psychiatry Res       Date:  2004-01-30       Impact factor: 3.222

4.  Assessment of motivation to change substance use in dually-diagnosed schizophrenia patients.

Authors:  Joanna E Strong Kinnaman; Alan S Bellack; Clayton H Brown; Ye Yang
Journal:  Addict Behav       Date:  2006-12-19       Impact factor: 3.913

5.  Stages of change profiles in outpatient alcoholism treatment.

Authors:  C C DiClemente; S O Hughes
Journal:  J Subst Abuse       Date:  1990

Review 6.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

7.  Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.

Authors:  S C Sigmon; S Steingard; G J Badger; S L Anthony; S T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2000-11       Impact factor: 3.157

8.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

9.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

10.  A randomized trial of assertive community treatment for homeless persons with severe mental illness.

Authors:  A F Lehman; L B Dixon; E Kernan; B R DeForge; L T Postrado
Journal:  Arch Gen Psychiatry       Date:  1997-11
View more
  7 in total

Review 1.  Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.

Authors:  Jesse Dallery; Bethany Raiff
Journal:  Am J Drug Alcohol Abuse       Date:  2011-12-13       Impact factor: 3.829

2.  Sexual orientation and substance use treatment outcomes across five clinical trials of contingency management.

Authors:  Kristyn Zajac; Carla J Rash; Meredith K Ginley; Nicholas C Heck
Journal:  Psychol Addict Behav       Date:  2019-07-25

Review 3.  Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.

Authors:  Jennifer W Tidey
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

Review 4.  Treatment of the depressed alcoholic patient.

Authors:  Jeffrey J DeVido; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

5.  Income does not affect response to contingency management treatments among community substance abuse treatment-seekers.

Authors:  Carla J Rash; Todd A Olmstead; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2009-07-08       Impact factor: 4.492

6.  Income received during treatment does not affect response to contingency management treatments in cocaine-dependent outpatients.

Authors:  Carla J Rash; Leonardo F Andrade; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2013-04-28       Impact factor: 4.492

7.  A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users.

Authors:  Michael B Drummond; Jacquie Astemborski; Allison A Lambert; Scott Goldberg; Maxine L Stitzer; Christian A Merlo; Cynthia S Rand; Robert A Wise; Gregory D Kirk
Journal:  BMC Public Health       Date:  2014-07-28       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.